Article Details
Retrieved on: 2024-11-18 18:08:42
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the extension of COVID-19-related telemedicine flexibilities for prescribing controlled substances till 2025. This affects health informatics, telemedicine, and eHealth, particularly in telepsychiatry and opioid use disorder management.
Article found on: www.healthcarefinancenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here